Encompass Health Co. (NYSE:EHC) EVP Sells $1,220,739.42 in Stock

Encompass Health Co. (NYSE:EHC) EVP John Patrick Darby sold 14,543 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the transaction, the executive vice president now owns 84,773 shares in the company, valued at approximately $7,115,845.62. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Encompass Health Trading Up 2.3 %

NYSE:EHC traded up $1.92 during trading hours on Tuesday, reaching $86.43. 277,504 shares of the company were exchanged, compared to its average volume of 659,227. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37. The firm has a market cap of $8.70 billion, a price-to-earnings ratio of 23.22, a PEG ratio of 1.30 and a beta of 0.92. The stock has a 50 day simple moving average of $79.33 and a 200 day simple moving average of $71.79. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $86.58.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company posted $0.88 earnings per share. The firm’s quarterly revenue was up 13.4% on a year-over-year basis. As a group, analysts predict that Encompass Health Co. will post 4.1 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be issued a $0.15 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.69%. Encompass Health’s dividend payout ratio is currently 16.22%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on EHC shares. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Mizuho raised their price target on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Raymond James reaffirmed a “strong-buy” rating and set a $95.00 target price (up previously from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Finally, Truist Financial lifted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and a consensus target price of $90.29.

Hedge Funds Weigh In On Encompass Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Principal Securities Inc. bought a new position in Encompass Health during the fourth quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. lifted its position in shares of Encompass Health by 360.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after purchasing an additional 317 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health during the fourth quarter worth $30,000. GAMMA Investing LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $33,000. Finally, C M Bidwell & Associates Ltd. bought a new position in Encompass Health during the third quarter worth about $35,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.